---
title: Improve walking speed and stability
nct_id: NCT07105787
phase: NA
status: RECRUITING
sponsor: University of Kiel
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT07105787"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07105787"
last_fetched: "2026-05-10T14:04:23.739Z"
source: "Parkinson's Pathways (curated)"
---
# Improve walking speed and stability

**Goal (in five words):** Improve walking speed and stability

**Official Title:** Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna

**Trial ID:** [NCT07105787](https://clinicaltrials.gov/study/NCT07105787)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** University of Kiel
- **Target Enrollment:** 42 participants
- **Start Date:** 2025-03-31
- **Completion Date:** 2026-03-31
- **Conditions:** Parkinson Disease, Falls
- **Interventions:** SDTT + VR triggered adaptations, Speed-dependent treadmill training (SDTT)
- **Intervention Types:** OTHER

## Summary For Families

The goal is to reduce falls and make everyday walking steadier by improving gait stability and adaptability in people with Parkinson's who already have trouble walking. The approach uses speed-dependent treadmill training, where the treadmill automatically matches and challenges your walking speed to retrain step timing and balance, combined with virtual-reality triggered changes that force quick adjustments so your brain and muscles learn to respond better; it is a rehabilitation program that complements usual Parkinson's medications rather than replacing them. They are looking for adults diagnosed with Parkinson's by MDS criteria, Hoehn and Yahr stages I to III, with at least a mild gait problem on the MDS‑UPDRS, who can walk one floor and do not have major cognitive impairment, severe depression, an implanted DBS device, or other health issues that make unsupervised exercise unsafe.

## Eligibility

- **Sex:** ALL

### Full Criteria

```
Inclusion criteria

1. Diagnosis of PD according to the MDS Criteria
2. Hoehn and Yahr stages I to III;
3. Movement Disorder Society-sponsored version of the Unified Parkinson Disease Rating Scale (MDS-UPDRS) gait sub-score of 1 or more
4. Signed informed consent to participation

Exclusion criteria

* Any known general health condition likely to interfere with or to pose a contraindication to non-medically supervised physical exercise.
* Moderate or severe depression (BDI-II ≥18)
* Cognitive impairment which may preclude the possibility to provide a fully informed consent to enrolment.
* Linguistic comprehension capacity less than 75% in ordinary conversation
* Severe psychiatric comorbidity which may interfere with compliance to the study protocol History of or current status of substance dependency
* Unable to walk less than 1 floor
* Thoracic pain in the last 4 weeks
* Currently enrolled in other interventional studies
* Implanted Deep Brain Stimulation device
```

## Locations (2)

- Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel _(32.0809, 34.7806)_
  - Jeffrey Hausdorff — (CONTACT) — +972-3-6973081 — jhausdor@tlvmc.gov.il
- IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy _(44.4938, 11.3387)_
  - Fabio Laporta — (CONTACT) — +39 051 208 0310 — fabio.laporta3@unibo.it

---

*Canonical: https://parkinsonspathways.com/trial/NCT07105787*  
*HTML version: https://parkinsonspathways.com/trial/NCT07105787*  
*Source data: https://clinicaltrials.gov/study/NCT07105787*